Cargando…

Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis

BACKGROUND: Cervical cancer (CC) is the second most common type of malignant tumor survival rate is low in advanced stage, metastatic, and recurrent CC patients. This study aimed at identifying potential genes and drugs for CC diagnosis and targeting therapies. METHODS: Three GEO mRNA microarray dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Hui-Zhu, Huang, Ji, Xiang, Cheng-Cheng, Li, Rong, Zuo, Er-Dong, Zhang, Yuan, Shan, Li, Cheng, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734488/ https://www.ncbi.nlm.nih.gov/pubmed/33302814 http://dx.doi.org/10.1177/1533033820980112

Ejemplares similares

Identification of novel biomarkers and candidate small molecule drugs in rheumatoid arthritis and osteoarthritis based on bioinformatics analysis of high‐throughput data
por: Zuo, Bin, et al.
Publicado: (2020)

Hierarchical virtual screening approaches in small molecule drug discovery
por: Kumar, Ashutosh, et al.
Publicado: (2015)

Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2023)

Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
por: Tang, Xin, et al.
Publicado: (2018)

Small molecule metabolites: discovery of biomarkers and therapeutic targets
por: Qiu, Shi, et al.
Publicado: (2023)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Epitope alteration by small molecules and applications in drug discovery
por: Zhu, Biyue, et al.
Publicado: (2022)

Recurrent Implantation Failure: Bioinformatic Discovery of Biomarkers and Identification of Metabolic Subtypes
por: Fan, Yuan, et al.
Publicado: (2023)

Bioinformatics-led discovery of ferroptosis-associated diagnostic biomarkers and molecule subtypes for tuberculosis patients
por: Wufuer, Dilinuer, et al.
Publicado: (2023)

Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease
por: Zhou, Le-Ting, et al.
Publicado: (2019)

Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer
por: Alam, Md Shahin, et al.
Publicado: (2022)

Bioinformatics screening of biomarkers related to liver cancer
por: Wang, Ye-Cheng, et al.
Publicado: (2021)

Bioinformatics and Drug Discovery
por: Xia, Xuhua
Publicado: (2017)

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
por: Cechetto, Jonathan, et al.
Publicado: (2011)

Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis
por: Chen, Juan, et al.
Publicado: (2019)

Identification of Potential Biomarkers and Small Molecule Drugs for Cutaneous Melanoma Using Integrated Bioinformatic Analysis
por: Liu, Yong, et al.
Publicado: (2022)

Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme
por: Qi, Fuwei, et al.
Publicado: (2020)

Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data
por: He, Yunan, et al.
Publicado: (2020)

Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis
por: Zhang, Ji-Zhou, et al.
Publicado: (2019)

Bioinformatics in translational drug discovery
por: Wooller, Sarah K., et al.
Publicado: (2017)

Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis
por: Morgan, Gareth J.
Publicado: (2021)

Integrative Bioinformatics Approaches to Screen Potential Prognostic Immune-Related Genes and Drugs in the Cervical Cancer Microenvironment
por: Zhao, Zitong, et al.
Publicado: (2020)

Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods
por: Wang, Dan, et al.
Publicado: (2022)

Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery
por: Li, Qingxin, et al.
Publicado: (2020)

Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data
por: Li, Chengrui, et al.
Publicado: (2021)

An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs
por: Ruiz-Torres, Verónica, et al.
Publicado: (2017)

Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy
por: Thippakorn, Chadinee, et al.
Publicado: (2018)

Discovery of small molecule cancer drugs: Successes, challenges and opportunities
por: Hoelder, Swen, et al.
Publicado: (2012)

Drug discovery inspired by bioactive small molecules from nature
por: Kim, Seyun, et al.
Publicado: (2022)

Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus
por: Alur, Varun, et al.
Publicado: (2021)

Biomarker discovery for tuberculosis using metabolomics
por: Yu, Yi, et al.
Publicado: (2023)

Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer
por: Reza, Md. Selim, et al.
Publicado: (2022)

Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis
por: Zeng, Yu, et al.
Publicado: (2021)

Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery
por: Ishida, Shigeharu, et al.
Publicado: (2014)

Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review
por: Zheng, Jia, et al.
Publicado: (2022)

Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis
por: Dai, Fangfang, et al.
Publicado: (2019)

Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors
por: Lin, Tony Eight, et al.
Publicado: (2021)

Discovery of CLEC2B as a diagnostic biomarker and screening of celastrol as a candidate drug for psoriatic arthritis through bioinformatics analysis
por: Niu, Min, et al.
Publicado: (2023)

Bioinformatics-Led Discovery of Osteoarthritis Biomarkers and Inflammatory Infiltrates
por: Hu, Xinyue, et al.
Publicado: (2022)

Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer
por: Huang, Shujun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mj7fd8jfbv7j7vdqhck40abk5n